[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ovary-anomaly\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ovary-anomaly":35},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,55],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":28,"conditions":29,"keywords":36,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100453223","phase-2-autologous-platelet-rich-plasma-intraovarian-infusion-for-poor-responders-100453223",false,"NCT05181748","Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders","Investigating the Efficiency of Autologous Platelet Rich Plasma Intraovarian Infusion on Improving Ovarian Functionality in Poor Ovarian Response Patients","PRPPOR","Inclusion Criteria:\n\nPoor Ovarian Response according to Bologna Criteria (fulfilling 2 out of 3 of the following):\n\n1. Age ≥ 40 years\n2. AMH \\\u003C 1.1 ng\u002Fml OR AFC \\\u003C 7\n3. ≤ 3 oocytes with a conventional stimulation protocol\n\n   * Discontinuation of any complementary\u002Fadjuvant treatment including hormone replacement and acupuncture, for at least three months prior to recruitment.\n   * Willing to comply with study requirements\n\nExclusion Criteria:\n\n* Any pathological disorder related to reproductive system anatomy\n* Cycle irregularities\n* Amenorrhea\n* Endometriosis\n* Adenomyosis\n* Fibroids and adhesions\n* Infections in reproductive system\n* Current or previous diagnosis of cancer in reproductive system\n* History of familiar cancer in reproductive system\n* Severe male factor infertility\n* Prior referral for Preimplantation Genetic Testing (PGT) -Ovarian inaccessibility -Endocrinological disorders (Hypothalamus-\n* Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)\n* BMI\\>30 kg\u002Fm2 or BMI\\\u003C18.5 kg\u002Fm2\n* Systematic autoimmune disorders",true,"FEMALE","35 Years","47 Years",{"count":22,"type":23},100,"ESTIMATED","INTERVENTIONAL",[26,27],"PHASE2","PHASE3","Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.",[30,31,32,33,34,35],"Poor Response to Ovulation Induction","Infertility, Female","Ovarian Insufficiency","Ovarian Failure","Reproductive Sterility","Ovary; Anomaly",[37,38,39,40,41],"Autologous platelet rich plasma intraovarian infusion","Assisted reproduction","PRP","In vitro fertilization","Ovarian functionality improvement","RECRUITING","2024-12-20",{"date":45,"type":46},"2024-12-27","ACTUAL",{"date":48,"type":46},"2019-01-23",{"date":50,"type":23},"2026-01-31",{"name":52,"class":53},"Genesis Athens Clinic","OTHER",1,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":39,"eligibilityCriteria":61,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":62,"targetDuration":4,"studyType":24,"phases":63,"briefSummary":64,"conditions":65,"keywords":4,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":66,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":54},"100357715","phase-2-autologous-platelet-rich-plasma-intra-ovarian-infusion-in-poor-responders-100357715","NCT03937661","Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders","Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Poor Responders","Inclusion Criteria:\n\n* Poor Ovarian Response according to Bologna Criteria (fulfilling 2 out of 3 of the following)\n* Age ≥ 40 years\n* AMH \\\u003C 1.1 ng\u002Fml OR AFC \\\u003C 7\n* ≤ 3 oocytes with a conventional stimulation protocol)\n* Discontinuation of any complementary\u002Fadjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.\n* Willing to comply with study requirements\n\nExclusion Criteria:\n\n* Any pathological disorder related to reproductive system anatomy\n* Cycle irregularities\n* Amenorrhea\n* Endometriosis\n* Adenomyosis\n* Fibroids and adhesions\n* Infections in reproductive system\n* Current or previous diagnosis of cancer in reproductive system\n* History of familiar cancer in reproductive system\n* Severe male factor infertility\n* Prior referral for PGT\n* Ovarian inaccessibility -Endocrinological disorders (Hypothalamus-\n* Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)\n* BMI\\>30 kg\u002Fm2 or BMI\\\u003C18.5 kg\u002Fm2\n* Systematic autoimmune disorders",{"count":22,"type":23},[26,27],"Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).",[35,31],{"date":45,"type":46},{"date":68,"type":46},"2019-05-06",{"date":70,"type":23},"2025-08-30",{"name":52,"class":53}]